Eli Lilly and Company
Neuregulin-4 compounds and methods of use
Last updated:
Abstract:
The present invention relates to neuregulin (NRG) 4 compounds and methods of treatment with NRG4 compounds.
Status:
Grant
Type:
Utility
Filling date:
31 Mar 2020
Issue date:
8 Feb 2022